Similarly, in both TCGA-ESCC and TCGA-HCC datasets, patients with a high SPP1 + SIRPα + macrophages signature score tended to have shorter overall survival (Fig. 5B and C). This evidence concerns the gene SIRPA and hepatocellular carcinoma.